Hypersensitivity pneumonitis associated with the use of temozolomide

Koschel D., Handzhiev S., Leucht V., Holotiuk O., Fisseler-Eckhoff A., Hoffken G.

Source: Eur Respir J 2009; 33: 931-934
Journal Issue: April
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Koschel D., Handzhiev S., Leucht V., Holotiuk O., Fisseler-Eckhoff A., Hoffken G.. Hypersensitivity pneumonitis associated with the use of temozolomide. Eur Respir J 2009; 33: 931-934

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Hypersensitivity pneumonitis associated with temozolomide
Source: Eur Respir J 2009; 33: 526
Year: 2009


Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease
Source: International Congress 2017 – Novel and old entities
Year: 2017

Rituximab for the treatment of chronic hypersensitivity pneumonitis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015

Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate
Source: Eur Respir J 2002; 19: 377-380
Year: 2002



Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017
Year: 2017



Hypersensitivity pneumonitis
Source: ERS Course 2016
Year: 2016




Hypersensitivity pneumonitis
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018

Hypersensitivity pneumonitis
Source: Annual Congress 2004 - PG10 - Occupational and environmental disorders of the lung parenchyma
Year: 2004


Hypersensitivity pneumonitis
Source: School Course 2014 - Interstitial lung diseases
Year: 2014


Hypersensitivity pneumonitis
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Hypersensitivity pneumonitis
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?
Source: Eur Respir J, 51 (1) 1701737; 10.1183/13993003.01737-2017
Year: 2018



Hypersensitivity pneumonitis caused by oral aspirin
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009


Treatment response in hypersensitivity pneumonitis
Source: International Congress 2016 – Orphan diseases II
Year: 2016


Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


Idelalisib-related pneumonitis
Source: Eur Respir J 2016; 47: 1280-1283
Year: 2016


Pembrolizumab-induced pneumonitis
Source: ERJ Open Res, 3 (2) 00081-2016; 10.1183/23120541.00081-2016
Year: 2017